The stent hadn’t helped after all; the impacted kidney had, in fact, been irreversibly damaged and was now functioning at a ...

Teleflex management announced a significant acquisition and business split, but the market reacted negatively. Read why I remain neutral on TFX stock.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

An ongoing study in Europe comparing it to Abbott’s Xience drug-eluting stent is set to report results ... forward Teleflex’s interventional urology, acute care and device manufacturing ...

Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

The acquisition reflects Teleflex’s commitment to investing in the estimated $10 billion interventional cardiology and peripheral vascular market served by the Company’s portfolio post close. 1,2 The ...

The stent is removed about 1 week after surgery ... Brahmbhatt, MD is co-Director of the Personalized Urology and Robotics (PUR) Clinic, Orlando Health South Lake Hospital, Clermont, Florida. He is ...

Key urology brands include the UroLift minimally ... The VI business, meanwhile, features products like the Orsiro drug-eluting stent, Pantera Lux drug-coated balloon catheter, PK Papyrus stent ...

The company’s urology, acute care, and OEM businesses will be grouped ... to include vascular intervention devices such as drug-coated balloons, drug-eluting stents, and balloon catheters. This would ...

A new trial refutes this finding. The subjects, 636 patients who underwent successful coronary stenting, were randomized to an initial intravenous bolus and a 6-month oral regimen of either ...

Early hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS) insertion, especially within the first 30 days, was associated with reduced survival in patients with ...

Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ..